Prazosin disposition in young and elderly subjects

Area of Science:

• Pharmacokinetics
• Geriatric Medicine
• Internal Medicine

Background:

• Prazosin is a medication used to treat high blood pressure.
• Age-related changes can affect drug disposition.
• Understanding prazosin pharmacokinetics in the elderly is crucial for safe and effective dosing.

Purpose of the Study:

• To investigate the disposition of prazosin in young and elderly men.
• To compare pharmacokinetic parameters such as half-life, clearance, volume of distribution, and bioavailability between age groups.
• To determine the factors contributing to altered prazosin pharmacokinetics in the elderly.

Main Methods:

• A pharmacokinetic study involving oral and intravenous administration of prazosin.
• Inclusion of healthy young (n=7) and elderly (n=7) male participants.
• Measurement and comparison of key pharmacokinetic parameters: elimination half-life, clearance, volume of distribution, and absolute bioavailability.

Main Results:

• Elderly men showed a significantly longer elimination half-life of prazosin (194 min) compared to young men (123 min).
• The volume of distribution at steady state was significantly larger in the elderly (0.89 L/kg) than in the young (0.63 L/kg).
• Absolute bioavailability of oral prazosin was lower in the elderly (0.48) compared to the young (0.68), indicating decreased gastrointestinal absorption with age.

Conclusions:

• The prolonged prazosin half-life in the elderly is primarily attributed to an increased volume of distribution, rather than decreased clearance.
• Reduced gastrointestinal absorption of prazosin occurs in old age.
• These findings suggest potential need for dosage adjustments in elderly patients to optimize prazosin therapy.